Science Benefactor Jeffrey Epstein Funds a Groundbreaking Cure for Crohns Disease

Profile of Jeffrey Epstein

The Science and Harvard Philanthropist, Jeffrey Epstein Backs the first real preventative drug for Crohns and Colitis Disease.

This is the first time that a treatment for Crohns and Colitis addresses the cause, instead of the symptoms.
— Jeffrey Epstein
NEW YORK, NY, USA, March 14, 2014 / -- Crohns and Colitis Disease is a devastating condition of the lower intestine and colon that causes inflammation and chronic symptoms from ulceration to intestinal rupture. Every year approximately 700,000 Americans are diagnosed with the disease and many more suffer from undiagnosed irritable bowel syndrome. Not much is known about what causes Crohns and Colitis, but for the first time in history, researchers are tackling the bacteria that cause the inflammation.

Founded by the science and Harvard philanthropist, Jeffrey Epstein, the Jeffrey Epstein VI Foundation has been an avid supporter of the Crohns and Colitis Foundation of America’s (CCFA) initiative to identify the bacteria that cause bowel inflammation. Specifically, the CCFA backs pivotal research called the Microbiome Initiative—which identifies 14 bacterial metabolic profiles associated with IBD.

To tackle these 14 bacteria types, researchers are developing the first line of inhibitors to block specific bacterial metabolic pathways, along with dietary supplements to redirect bacterial metabolites.

"This is the first time that a treatment for Crohns and Colitis addresses the cause, instead of the symptoms," Jeffrey Epstein remarked. "Even though we don’t know the root cause of the disease, except for a possible genetic disposition, drugs will soon block the bacteria that cause inflammation."

"We anticipate that in the next three to five years, we will have isolated microbial targets and develop strategies that will form the basis for new therapeutic interventions," Dr. R.Balfour Sator stated, who is CCFA Chief Medical Advisor and Midget Distinguished Professor of Medicine, Microbiology & Immunology, and Director of the UNC Multidisciplinary IBD Center.

The Jeffrey Epstein VI Foundation also supports the CCFA’s Genetics Initiative which focuses on the more than 100 internationally-identified genetic factors that contribute to IBD risk. To date, seven high-priority genetic pathways that regulate immune function or the intestinal lining cell response to injury have been targeted for intensive investigation for inhibitor therapy.

Jeffrey Epstein is the founder of the Program for Evolutionary Dynamics at Harvard University. He is also a former board member of the Mind, Brain and Behavior Committee at Harvard and a former board member of Rockefeller University.

Press release courtesy of Of Online PR Media.

Jeffrey Epstein
Jeffrey Epstein VI Foundation
(917) 573-7604
email us here